292 related articles for article (PubMed ID: 24850080)
1. Neurophysiological biomarkers informing the clinical neuroscience of schizophrenia: mismatch negativity and prepulse inhibition of startle.
Light GA; Swerdlow NR
Curr Top Behav Neurosci; 2014; 21():293-314. PubMed ID: 24850080
[TBL] [Abstract][Full Text] [Related]
2. Animal Models of Deficient Sensorimotor Gating in Schizophrenia: Are They Still Relevant?
Swerdlow NR; Light GA
Curr Top Behav Neurosci; 2016; 28():305-25. PubMed ID: 27311762
[TBL] [Abstract][Full Text] [Related]
3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
4. Characterization of neurophysiologic and neurocognitive biomarkers for use in genomic and clinical outcome studies of schizophrenia.
Light GA; Swerdlow NR; Rissling AJ; Radant A; Sugar CA; Sprock J; Pela M; Geyer MA; Braff DL
PLoS One; 2012; 7(7):e39434. PubMed ID: 22802938
[TBL] [Abstract][Full Text] [Related]
5. Future clinical uses of neurophysiological biomarkers to predict and monitor treatment response for schizophrenia.
Light GA; Swerdlow NR
Ann N Y Acad Sci; 2015 May; 1344(1):105-19. PubMed ID: 25752648
[TBL] [Abstract][Full Text] [Related]
6. Endophenotypes in Schizophrenia: Digging Deeper to Identify Genetic Mechanisms.
Greenwood TA; Shutes-David A; Tsuang DW
J Psychiatr Brain Sci; 2019; 4(2):. PubMed ID: 31245629
[TBL] [Abstract][Full Text] [Related]
7. Neurophysiological Biomarkers in Schizophrenia-P50, Mismatch Negativity, and TMS-EMG and TMS-EEG.
Kim HK; Blumberger DM; Daskalakis ZJ
Front Psychiatry; 2020; 11():795. PubMed ID: 32848953
[TBL] [Abstract][Full Text] [Related]
8. Single-Dose Memantine Improves Cortical Oscillatory Response Dynamics in Patients with Schizophrenia.
Light GA; Zhang W; Joshi YB; Bhakta S; Talledo JA; Swerdlow NR
Neuropsychopharmacology; 2017 Dec; 42(13):2633-2639. PubMed ID: 28425497
[TBL] [Abstract][Full Text] [Related]
9. Neurophysiological Characterization of Attentional Performance Dysfunction in Schizophrenia Patients in a Reverse-Translated Task.
Young JW; Bismark AW; Sun Y; Zhang W; McIlwain M; Grootendorst I; Light GA
Neuropsychopharmacology; 2017 May; 42(6):1338-1348. PubMed ID: 27917869
[TBL] [Abstract][Full Text] [Related]
10. Neurophysiological endophenotypes across bipolar and schizophrenia psychosis.
Thaker GK
Schizophr Bull; 2008 Jul; 34(4):760-73. PubMed ID: 18502737
[TBL] [Abstract][Full Text] [Related]
11. Mismatch Negativity is a Sensitive and Predictive Biomarker of Perceptual Learning During Auditory Cognitive Training in Schizophrenia.
Perez VB; Tarasenko M; Miyakoshi M; Pianka ST; Makeig SD; Braff DL; Swerdlow NR; Light GA
Neuropsychopharmacology; 2017 Oct; 42(11):2206-2213. PubMed ID: 28139679
[TBL] [Abstract][Full Text] [Related]
12. Approaches to neuromodulation for schizophrenia.
Gault JM; Davis R; Cascella NG; Saks ER; Corripio-Collado I; Anderson WS; Olincy A; Thompson JA; Pomarol-Clotet E; Sawa A; Daskalakis ZJ; Lipsman N; Abosch A
J Neurol Neurosurg Psychiatry; 2018 Jul; 89(7):777-787. PubMed ID: 29242310
[TBL] [Abstract][Full Text] [Related]
13. [Neurophysiological differentiation of personality disorders].
Kirenskaya AV; Samylkin DV; Storozheva ZI; Myamlin VV; Tkachenko AA
Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(11):124-130. PubMed ID: 36440789
[TBL] [Abstract][Full Text] [Related]
14. Impaired startle prepulse inhibition and habituation in patients with schizotypal personality disorder.
Cadenhead KS; Geyer MA; Braff DL
Am J Psychiatry; 1993 Dec; 150(12):1862-7. PubMed ID: 8238643
[TBL] [Abstract][Full Text] [Related]
15. Preattentional and attentional cognitive deficits as targets for treating schizophrenia.
Braff DL; Light GA
Psychopharmacology (Berl); 2004 Jun; 174(1):75-85. PubMed ID: 15118804
[TBL] [Abstract][Full Text] [Related]
16. Deficits in Pre-attentive Processing of Spatial Location and Negative Symptoms in Subjects at Clinical High Risk for Schizophrenia.
Sehatpour P; Avissar M; Kantrowitz JT; Corcoran CM; De Baun HM; Patel GH; Girgis RR; Brucato G; Lopez-Calderon J; Silipo G; Dias E; Martinez A; Javitt DC
Front Psychiatry; 2020; 11():629144. PubMed ID: 33603682
[TBL] [Abstract][Full Text] [Related]
17. Neurophysiological endophenotypes of schizophrenia: the viability of selected candidate measures.
Turetsky BI; Calkins ME; Light GA; Olincy A; Radant AD; Swerdlow NR
Schizophr Bull; 2007 Jan; 33(1):69-94. PubMed ID: 17135482
[TBL] [Abstract][Full Text] [Related]
18. Neural substrates of normal and impaired preattentive sensory discrimination in large cohorts of nonpsychiatric subjects and schizophrenia patients as indexed by MMN and P3a change detection responses.
Takahashi H; Rissling AJ; Pascual-Marqui R; Kirihara K; Pela M; Sprock J; Braff DL; Light GA
Neuroimage; 2013 Feb; 66():594-603. PubMed ID: 23085112
[TBL] [Abstract][Full Text] [Related]
19. Cortical substrates and functional correlates of auditory deviance processing deficits in schizophrenia.
Rissling AJ; Miyakoshi M; Sugar CA; Braff DL; Makeig S; Light GA
Neuroimage Clin; 2014; 6():424-37. PubMed ID: 25379456
[TBL] [Abstract][Full Text] [Related]
20. Neurophysiological Effects of Bitopertin in Schizophrenia.
Kantrowitz JT; Nolan KA; Epstein ML; Lehrfeld N; Shope C; Petkova E; Javitt DC
J Clin Psychopharmacol; 2017 Aug; 37(4):447-451. PubMed ID: 28590364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
